The latest price target for CytoSorbents (NASDAQ:CTSO) was reported by D. Boral Capital on March 26, 2026. The analyst firm set a price target for $10.00 expecting CTSO to rise to within 12 months (a possible 1627.41% upside). 12 analyst firms have reported ratings in the last year.

The latest analyst rating for CytoSorbents (NASDAQ:CTSO) was provided by D. Boral Capital, and CytoSorbents maintained their buy rating.

There is no last upgrade for CytoSorbents

The last downgrade for CytoSorbents Corp happened on December 29, 2023 when HC Wainwright & Co. changed their price target from $5.5 to $1 for CytoSorbents Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CytoSorbents, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CytoSorbents was filed on March 26, 2026 so you should expect the next rating to be made available sometime around March 26, 2027.

While ratings are subjective and will change, the latest CytoSorbents (CTSO) rating was a maintained with a price target of $10.00 to $10.00. The current price CytoSorbents (CTSO) is trading at is $0.58, which is out of the analyst’s predicted range.